https://www.selleckchem.com/pr....oducts/dibutyryl-cam
ObjectiveEffects of drugs or immunotherapy on the quality of life of adult patients with allergic rhinitis(AR) were assessed using the rhinoconjunctivitis quality of life questionnaire(RQLQ). MethodA total of 142 patients were included, including 37 patients receiving specific immunotherapy(SIT)(SIT group). The remaining 105 patients received standardized drug treatment, and were divided into 87 cases in the receiving drug application instruction group(A1 group) and 18 cases in the non-receiving drug application instr